BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//LifeSci Events - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LifeSci Events
X-ORIGINAL-URL:https://lifescievents.com
X-WR-CALDESC:Events for LifeSci Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261020T110000
DTEND;TZID=America/New_York:20261020T120000
DTSTAMP:20261016T132331Z
CREATED:20261008T205232Z
LAST-MODIFIED:20261016T132331Z
UID:3679-1792494000-1792497600@lifescievents.com
SUMMARY:Aprea Therapeutics\, Inc. Pre-ESMO Virtual Panel: The State of WEE1 Inhibition in Precision Oncology
DESCRIPTION:Disrupting the DNA damage response has become a compelling therapeutic strategy in oncology in recent years and WEE1 inhibitors are among the most promising drugs being developed within this class.  Ahead of the European Society for Medical Oncology (ESMO) Congress 2026\, this panel will cover the underlying biology of WEE1\, the selectivity challenge that has shaped the class\, and what to watch in the months ahead\, across scientific\, clinical\, and market perspectives.  Moderated by Solomon Wilcots\, NFL broadcaster and former player for the Cincinnati Bengals\, the panel will feature the following participants: \n\nAlex Spira\, Director of the Thoracic and Phase I Program at the Virginia Cancer Specialists Research Institute\, Chief Scientific Officer of NEXT Oncology and Clinical Assistant Professor at Johns Hopkins School of Medicine.\nKevin DeGeeter Managing Director in equity research at Ladenburg Thalmann & Co. Inc.\nEugene Kennedy\, Chief Medical Advisor of Aprea Therapeutics\, Inc. Watch the webcast by clicking this link and logging in with the email address you used to register: https://lifescievents.com/event/ahe93pl/.
URL:https://lifescievents.com/event/ahe93pl/
LOCATION:Virtual\, Virtual
ATTACH;FMTTYPE=image/png:https://lifescievents.com/wp-content/uploads/2026/10/Aprea-Therapeutics.png
END:VEVENT
END:VCALENDAR